Pharmacologic interventions for painful diabetic neuropathy: An umbrella systematic review and comparative effectiveness network meta-analysis (Protocol)

Systematic Reviews

Volumn 1, Issue 1, 2012, Pages

  Griebeler, Marcio L ^a   Tsapas, Apostolos ^b   Brito, Juan P ^a   Wang, Zhen ^c   Phung, Olivia J ^a   Montori, Victor M ^a   Murad, M H ^a  

^a MAYO CLINIC   (United States)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

Author keywords

Comparative effectiveness research; Diabetic neuropathy; Network meta analysis; Systematic review

Indexed keywords

AMITRIPTYLINE; CAPSAICIN; CARBAMAZEPINE; DESIPRAMINE; DOXEPIN; DULOXETINE; EPALRESTAT; FIDARESTAT; GABAPENTIN; HARKOSERIDE; IMIPRAMINE; LAMOTRIGINE; LIDOCAINE; MEXILETINE; MORPHINE; NORTRIPTYLINE; OXCARBAZEPINE; OXYCODONE; PAROXETINE; PONALRESTAT; PREGABALIN; RANIRESTAT; SORBINIL; TAPENTADOL; TOPIRAMATE; TRAMADOL; VALPROIC ACID; VENLAFAXINE; ANALGESIC AGENT;

ARTICLE; COMPARATIVE EFFECTIVENESS; DIABETIC NEUROPATHY; DRUG EFFICACY; HUMAN; META ANALYSIS; PUBLICATION; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; TREATMENT OUTCOME; REVIEW;

ANALGESICS; COMPARATIVE EFFECTIVENESS RESEARCH; DIABETIC NEUROPATHIES; HUMANS;

MLCS; MLOWN;

EID: 84876190653     PISSN: None     EISSN: 20464053     Source Type: Journal    
DOI: 10.1186/2046-4053-1-61     Document Type: Article

References (20)

1. Benbow SJ, Wallymahmed ME, MacFarlane IA. Diabetic peripheral neuropathy and quality of life. QJM 1998, 91:733-737. 10.1093/qjmed/91.11.733, 10024935.
2. Wong MC, Chung JW, Wong TK. Effects of treatments for symptoms of painful diabetic neuropathy: systematic review. BMJ 2007, 335:87. 10.1136/bmj.39213.565972.AE, 1914460, 17562735.
3. Boulton AJ. Pharmacologic management of painful diabetic neuropathy. Curr Diab Rep 2008, 8:429-430. 10.1007/s11892-008-0074-2, 18990297.
4. Bril V, England J, Franklin GM, Backonja M, Cohen J, Del Toro D, Feldman E, Iverson DJ, Perkins B, Russell JW, Zochodne D, American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, American Academy of Physical Medicine and Rehabilitation Evidence-based guideline: treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 2011, 76:1758-1765. 10.1212/WNL.0b013e3182166ebe, 3100130, 21482920, American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, American Academy of Physical Medicine and Rehabilitation.
5. Boulton AJ. Pharmacologic management of painful diabetic neuropathy. Curr Diab Rep 2008, 8:429-430. 10.1007/s11892-008-0074-2, 18990297.
6. Lindsay TJ, Rodgers BC, Savath V, Hettinger K. Treating diabetic peripheral neuropathic pain. Am Fam Physician 2010, 82:151-158.
7. Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, Malik RA, Maser RE, Sosenko JM, Ziegler D. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 2005, 28:956-962. 10.2337/diacare.28.4.956, 15793206.
8. Higgins JPGS. Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0. , http://www.cochrane-handbook.org
9. Domecq JP, Prutsky G, Wang Z, Elraiyah T, Brito JP, Mauck K, Lababidi MH, Leppin A, Fidahusse S, Prokop LJ, Montori VM, Murad MH. Drugs commonly associated with weight change: umbrella systematic review and meta-analysis (Protocol). Syst Rev 2012, 1:44. 10.1186/2046-4053-1-44, 23020969.
10. Balshem H, Helfand M, Schünemann HJ, Oxman AD, Kunz R, Brozek J, Vist GE, Falck-Ytter Y, Meerpohl J, Norris S, Guyatt GH. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol 2011, 64:401-406. 10.1016/j.jclinepi.2010.07.015, 21208779.
11. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188. 10.1016/0197-2456(86)90046-2, 3802833.
12. Lumley T. Network meta-analysis for indirect treatment comparisons. Stat Med 2002, 21:2313-2324. 10.1002/sim.1201, 12210616.
13. Lambert PC, Sutton AJ, Burton PR, Abrams KR, Jones DR. How vague is vague? A simulation study of the impact of the use of vague prior distributions in MCMC using WinBUGS. Stat Med 2005, 24:2401-2428. 10.1002/sim.2112, 16015676.
14. Furukawa TA, Barbui C, Cipriani A, Brambilla P, Watanabe N. Imputing missing standard deviations in meta-analyses can provide accurate results. J Clin Epidemiol 2006, 59:7-10. 10.1016/j.jclinepi.2005.06.006, 16360555.
15. Lu G, Ades AE. Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med 2004, 23:3105-3124. 10.1002/sim.1875, 15449338.
16. Salanti G, Higgins JP, Ades AE, Ioannidis JP. Evaluation of networks of randomized trials. Stat Methods Med Res 2008, 17:279-301.
17. Caldwell DM, Welton NJ, Ades AE. Mixed treatment comparison analysis provides internally coherent treatment effect estimates based on overviews of reviews and can reveal inconsistency. J Clin Epidemiol 2010, 63:875-882. 10.1016/j.jclinepi.2009.08.025, 20080027.
18. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994, 50:1088-1101. 10.2307/2533446, 7786990.
19. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634. 10.1136/bmj.315.7109.629, 2127453, 9310563.
20. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 2009, 62:e1-34. 10.1016/j.jclinepi.2009.06.006, 19631507.